Psychiatry & Neurology Doctors in Waycross, GA Accepting Medicare

7 Psychiatry & Neurology doctors found. Showing 1 - 7

Nimi Patel, Psychiatry & Neurology - Neurology Medicare: May Accept Medicare Assignments Practice Location: 2101 Tebeau St, Waycross, GA 31501 Phone: 912-285-5690    Fax: 912-285-1753

Fady Henein, MD Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 1007 Mary St, Waycross, GA 31503 Phone: 734-819-4211

Dr. John F Michaels Jr., M.D. Psychiatry & Neurology - Psychiatry Medicare: May Accept Medicare Assignments Practice Location: 1707 Boulevard Sq, Suite A, Waycross, GA 31501 Phone: 912-490-0078    Fax: 912-490-0048

Lionel Bryan, MD Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 1007 Mary St, Waycross, GA 31503 Phone: 912-449-7100

Dr. David Samuel Roth, M.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 1007 Mary St, Waycross, GA 31503 Phone: 912-449-7207    Fax: 912-284-2582

Jaymal R Patel, M.D. Psychiatry & Neurology - Psychiatry Medicare: May Accept Medicare Assignments Practice Location: 1900 Tebeau St, Waycross, GA 31501 Phone: 912-283-3030

Michael P Baker, M.D. Psychiatry & Neurology - Neurology Medicare: Not Enrolled in Medicare Practice Location: 2101 Tebeau St, Waycross, GA 31501 Phone: 912-285-5690    Fax: 912-285-1753

News Archive

U.S. District Court grants preliminary injunction, clears sale of Dr. Reddy's Allegra D24 tablet

Dr. Reddy's Laboratories announced today that on Friday, 28 January 2011, the U.S. District Court of New Jersey filed a Stipulation and Order lifting an earlier motion for preliminary injunction and clearing the sale of Dr. Reddy's generic product version of Allegra D24, which was approved by the FDA on March 16, 2010.

Iroko Cardio International Sàrl announces data on HDB dosing of tirofiban, abciximab in interventional cardiology

Iroko Cardio International Sàrl announces long-term, three-year, mortality data from the Phase III, open label, multi-national study comparing high-dose bolus (HDB) dosing of AGGRASTAT(tirofiban) (25mcg/kg bolus followed by a 0.15mcg/kg/min infusion for 18-24 hours) vs. ReoPro (abciximab) in patients undergoing primary percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI), presented at the 2010 European Society of Cardiology Meeting in Stockholm, Sweden.

Laser Med Center receives FDA approval for device to treat Trigeminal Neuralgia

Laser Med Center, which specializes in treating Trigeminal Neuralgia, has received an FDA approval for its revolutionary laser device. This is a non-invasive alternative to surgery, which treats pain through nerve tissue regeneration.

Nationwide Health Properties to redeem outstanding shares of Series B Preferred Stock

Nationwide Health Properties, Inc. announced today that it has given notice that it is redeeming all of its outstanding shares of 7.75% Series B Cumulative Convertible Preferred Stock ("Series B Preferred Stock") (NHP-PB - CUSIP No. 638620302) on January 18, 2010 at a redemption price per share of $103.875 plus an amount equal to accumulated and unpaid dividends thereon to the redemption date ($0.3875), for a total redemption price of $104.2625 per share.

Read more Medical News

› Verified 3 days ago